Identifying, building and investing in exceptional startups


What we do

We identify, build and invest in innovative startup companies founded on strong science, with the ultimate goal of developing products that can transform patient treatment.

From startup to exit

Collaborating with outstanding researchers, academic institutions, entrepreneurs and leaders in the biotech and pharma industry, we provide capital, network and know-how to transform promising life-science discoveries into successful biotech startups.

With this platform, we strive to be the preferred early-stage investor and partner of the European life science industry.

Covering the spectrum from early-stage discoveries to clinical-stage companies, we focus on two main areas:

  • company creation and building biotech startups in the Nordic region;
  • early-stage investments in promising biotech and medtech companies in the rest of Europe

We aim to develop strong and competitive companies that we finance all the way to a commercial exit.

In 2017, we invested about DKK 175 million in new companies, and we currently have 21 active portfolio companies. In the coming years, we will continue to increase our investments activities in both the Nordics and other parts of Europe.

Seeding great ideas

Through our hands-on approach, we ensure that promising projects and startup companies have the optimal conditions for success.




Meet our team

Novo Seeds is comprised of a team of passionate investment professionals, dedicated to working with scientists and entrepreneurs to build the healthcare companies of the future.

  • 22

    current portfolio companies.

  • 2000

    projects and companies reviewed since 2007.

  • 4

    exits since 2007.

Our headquarters

The Novo Seeds team is based at our headquarters in Copenhagen, Denmark.

Novo Holdings A/S
Tuborg Havnevej 19
2900 Hellerup
+45 3527 6500

CVR# 24257630

Novo Holdings uses cookies to ensure that we give you the best experience on our website. Read more